Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Talis Biomedical Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 22 | 22 | 0 |
| Shares | 11.8M | 11.0M | −775.4K (−6.6%) |
| Value | $5.76M | $5.27M | −$489.8K (−8.5%) |
New holders (3)
Institutions that held Talis Biomedical Corp at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 49,007 | $23.5K | 0.00% |
| Citadel Advisors LLC | 38,876 | $18.7K | 0.00% |
| Susquehanna International Group, LLP | 10,476 | $5.03K | 0.00% |
Sold out (3)
Institutions that held Talis Biomedical Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ArrowMark Colorado Holdings LLC | 478,862 | $234.6K |
| Prelude Capital Management, LLC | 223,934 | $109.7K |
| Mercer Global Advisors Inc | 79,880 | $39.0K |